Charlevoix-SaguenayÀÇ »ó¿°»öü¿¼º°Á÷½ÇÁ¶
Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
ºÀÁ¤ºó, ±è½Â¿ì, À̽ÂÅÂ, ÃÖÁ¾¶ô, ½ÅÇÏ¿µ,
¼Ò¼Ó »ó¼¼Á¤º¸
ºÀÁ¤ºó ( Bong Jeong-Bin )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
±è½Â¿ì ( Kim Seung-Woo )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
À̽ÂÅ ( Lee Seung-Tae )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
ÃÖÁ¾¶ô ( Choi Jong-Rak )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
½ÅÇÏ¿µ ( Shin Ha-Young )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
Abstract
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), which is caused by mutations in SACS gene, is a very rare neurodegenerative disorder characterized by the clinical triad of early onset cerebellar ataxia, pyramidal tract features, and sensorimotor polyneuropathy. Herein, we report a 35-year-old Korean male who presented with gait disturbance and lower extremity weakness. Neuroimaging and ophthalmologic evaluation revealed features consistent with ARSACS. Mutation in SACS gene was demonstrated in clinical exome sequence analysis and the patient was finally diagnosed as ARSACS.
Å°¿öµå
Spastic ataxia Charlevoix-Saguenay type; Cerebellar Ataxia; SACS gene
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸